Status | Study |
Recruiting |
Study Name: Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery Condition: Head and Neck Squamous Cell Carcinoma Laryngeal Squamous Cell Carcinoma, Spindle Cell Varian Date: 2016-04-06 Interventions: Drug: Cisplatin Given IV |
Recruiting |
Study Name: Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity Condition: Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Stage III Date: 2014-11-17 Interventions: Radiation: hypofractionated radiation therapy |
Terminated |
Study Name: Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Condition: Recurrent Hypopharyngeal Squamous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Date: 2014-07-18 Interventions: Drug: Cisplatin Given IV |
Active, not recruiting |
Study Name: Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy Condition: Mucositis Oral Complications Recurrent Adenoid Cystic Carc Date: 2014-04-23 Interventions: Drug: acetylcysteine Oral rins |
Withdrawn |
Study Name: Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity Condition: Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcino Date: 2014-04-17 Interventions: Drug: HPPH Undergo photodynami |
Terminated |
Study Name: Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer Condition: Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Laryngeal Verruc Date: 2014-02-18 Interventions: Other: Laboratory Biomarker Analysis |
Active, not recruiting |
Study Name: Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Recurrent Metast Date: 2014-01-10 Interventions: Drug: sorafenib tosylate Given |
Completed |
Study Name: Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery Condition: Recurrent Hypopharyngeal Squamous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Date: 2013-12-04 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care Condition: Lip and Oral Cavity Squamous Cell Carcinoma Oral Cavity Verrucous Carc Date: 2013-03-20 Interventions: Procedure: fluorescence imaging |
Withdrawn |
Study Name: Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy Condition: Mucositis Recurrent Squamous Cell Carcinoma of the Hypopharynx Date: 2012-11-13 Interventions: Drug: entolimod Given SC |